Article Information
History
- January 17, 2023.
Article Versions
- Version 1 (December 13, 2022 - 17:33).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1Corporal Michael J. Crescenz Veterans’ Administration Medical Center, Philadelphia, PA, USA
- 2Department of Dermatology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
- 3Department of Biostatistics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
- 4Department of Cardiovascular Sciences, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
- ↵‡To whom correspondence should be addressed: Kevin Jon Williams, MD, Professor of Cardiovascular Sciences, Professor of Medicine Lewis Katz School of Medicine at Temple University Medical Research Building (MRB), 3420 North Broad Street, Room 220, Philadelphia PA 19140 USA, eMAIL: kjwilliams{at}temple.edu
Posted January 17, 2023.
THE STATE OF CURRENT MANAGEMENT OF THE HEIGHTENED RISK FOR ATHEROSCLEROTIC CARDIOVASCULAR EVENTS IN AN ESTABLISHED COHORT OF PATIENTS WITH LUPUS ERYTHEMATOSUS
